Who we are

Board of Directors

• 

  Christian Hill

  Chief Executive Officer

  

  Christian Hill

  Chief Executive Officer

  Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.

  Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.
  

• 

  Dawn Hill

  Chief Operating Officer

  

  Dawn Hill

  Chief Operating Officer

  MAP was founded by Dawn who has worked in national and local government departments ranging from Business, Agriculture, Education and Finance for over twenty years.

  This experience was primarily focused on business and administration processes and, importantly for MAP BioPharma, the simplification and efficiency of these processes.

  Dawn therefore founded MAP BioPharma Limited and combines business and administration expertise with contacts in the Health Service, Biotech and Pharmaceutical sectors to deliver valuable resources to support Market Access for medicines in the UK and Ireland.

• 

  Nick Bruce

  Chief Consulting Officer

  

  Nick Bruce

  Chief Consulting Officer

  Nick worked as an NHS economist and commissioner at Health Authorities in South West London, during which time he held an honorary lectureship at St George’s Hospital Medical School, London. After leaving the NHS, Nick worked for a health economics consultancy before joining Pfizer in 1998 to set up its market access team. In a twenty year pharmaceutical industry career at Pfizer and Amgen, he held UK Leadership Team roles responsible for market access, health policy, government affairs and media communications. Nick was an ABPI representative on the Scottish Medicines Consortium appraisal committee, and a former member of the ABPI Board of Management.

• 

  Ian Keith

  Operations Director

  

  Ian Keith

  Operations Director

• 

  Mark Harries

  Director

  

  Mark Harries

  Director

  Mark has in-depth understanding and experience of Health Technology Appraisals in the UK, Europe and US, optimising submissions to achieve successful outcomes for both primary care and specialist products including orphan drugs. Mark joined MAP in 2014, prior to this he spent 6 years at WG Consulting as Managing Director, driving one of the highest levels of performance within the market access industry. Previously, Mark was a pharmacist in the NHS for 14 years, with his last position being Lead Directorate Pharmacist of Paediatric and Adolescent Medicine at University College London Hospitals NHS Trust.

  Mark has worked on a diverse range of Market Access consultancy programmes in the EU and US and offers an in-depth understanding of the issues and opportunities for a product at all stages in its lifecycle with the ability to provide the right solutions for clients, which will resonate with a variety of stakeholders at a clinician or payer level.

• 

  Andy Swarbrick

  Chairman

  

  Andy Swarbrick

  Chairman

  Andy brings with him 30 years of experience as a partner at Deloitte in Cambridge. He has a strong commercial background and an array of skills in financial management, strategic planning, HR and marketing both from an advisory perspective and from a career spent in various management roles within Deloitte. Pragmatic but with great attention to detail, an enquiring mind and a “can do” approach, he has much experience of building relationships and alliances, strong political skills and very significant experience in the owner manager/entrepreneurial and charity sectors. His various roles within the Deloitte Cambridge office ranged from Staff Partner, to Head of Business Development, to Head of Audit and to Senior Partner. He was for many years a Trustee of the Deloitte staff pension fund.

  His other current roles include Chairman of an executive search business and Non Exec Director of a regional law firm. For over 30 years he has been a trustee of an employee trust that owns a laboratory supply business. He also works with a number of charitable organisations, being a Trustee/Director of the Cambridge Arts Theatre and until very recently the Arthur Rank Hospice Charity. He is also Chairman of the Cambridge Music Festival and a member of the Advisory Council of the London Philharmonic Orchestra.

Business Development

• 

  Christian Hill

  Chief Executive Officer

  

  Christian Hill

  Chief Executive Officer

  Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.

  Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.
  

• 

  Sarah Borley

  Marketing Associate

  

  Sarah Borley

  Marketing Associate

  Sarah first joined MAP in September 2017 as a Receptionist before progressing to MAP Online Support, helping to develop and maintain client relationships. She brings her experience of administration and customer care to the MAP Online team, helping our clients throughout their membership. Prior to this, Sarah studied childcare at Cambridge Regional College and had worked in childcare for 6 years, before changing career direction.

• 

  Nicola Herridge

  MAP Online Relationship Manager

  

  Nicola Herridge

  MAP Online Relationship Manager

  Nicola's experience comes from working as a Bank Manager within the retail finance industry; Nicola comes to MAP having spent a little over 21 years with one of the largest retail banks in Britain. Nicola has managed teams to build and deepen relationships while delivering excellent customer service, and holds a level 3 Certificate in Retail Banking and Conduct of Business from the Institute of Financial Services.

• 

  Sarah Coates

  Marketing Manager

  

  Sarah Coates

  Marketing Manager

  With 20 years’ experience of working in senior marketing and communications roles, Sarah has developed high-impact strategic communications within diverse environments, including non-profit, start-up, and corporate organisations. Passionate about the client experience, understanding the complete client journey and tailoring marketing campaigns and messages to drive business results.

  Sarah has worked in sales and marketing in a range of senior positions including Cambridge University Press, in both their academic and education publishing divisions. More recently Sarah worked for My Inhouse Lawyer, setting up their lead generation programme and CRM. She also enjoyed supporting a local children’s charity Blue Smile as a marketing consultant at a critical phase of their growth.

• 

  Andrew Dec

  Events and Marketing Consultant

  

  Andrew Dec

  Events and Marketing Consultant

  With 25 years’ commercial marketing experience and a strong track record of delivering complex campaigns, Andy’s work is characterised by attention to detail, strong project management and a thorough understanding of the marketing mix.

  Andy brings a unique combination of skills to MAP, spanning both the public and private sector. He regularly leads high performance teams to deliver mission critical events, conferences and integrated marketing initiatives.

  He is adept at strategic analysis, report presentation and market research techniques. The projects Andy runs are always underpinned by robust systems and processes.

MAP Online

• 

  Adam Charlton

  Associate Director of Technology

  

  Adam Charlton

  Associate Director of Technology

  Adam joined MAP in January 2019 as IT Manager, focusing on Systems Development. Adam contributes over 15 years experience in cross platform software development, system architecture and implementation to the MAP team. Previously, Adam was a member of the Apple Consultants Network, and is an Apple Certified Technical Coordinator.

• 

  Stephen Norton PhD

  MAP Online Consultant

  

  Stephen Norton PhD

  MAP Online Consultant

  Stephen leads research and development of MAP Online and is a facilitator of the NICE META tool. Stephen joined MAP from Anglia Ruskin University where he advised researchers in winning funding. This followed time managing schemes for the BBSRC, the major national funder of biological research. Stephen completed a PhD in Biophysics of an Amyloid Protein at the University of Warwick, where he also gained a Master’s degree in Mathematical Biology and Biophysical Chemistry. His Bachelor’s degree, from Lancaster University, is in Biomedicine and Medical Statistics.
  

• 

  Douglas Hall

  MAP Online Consultant

  

  Douglas Hall

  MAP Online Consultant

  Doug's role at MAP combines development for new content for MAP Online, provision of strategic advice and support to MAP members, and ad-hoc research and consulting work for members and clients.

  Doug has been with MAP for a year and a half, and has developed a broad range of market access experience, with particular focuses in pricing, access and affordability, tariff arrangements and commissioning in England, advanced therapies (ATMPs), and the UK private health market.

  Prior to joining MAP, Doug did his PhD in Medical Research at the University of Cambridge, conducting research with Cancer Research UK in the lab of a clinician researcher. Prior to this he studied for an undergraduate Master's degree in Biochemistry at the University of Oxford.

• 

  Natasha Elmore

  Associate Consultant MAP Online

  

  Natasha Elmore

  Associate Consultant MAP Online

  Natasha has had a career spanning over 12 years in health services research before transitioning to market access. Her background in is psychology, with a BSc in psychology and an accredited Master’s degree in Health Psychology.
  Prior to joining MAP, Natasha was an Analyst in the Innovation, Health and Science team, at RAND Europe, based in Cambridge, UK, where she worked on various projects related to health and healthcare with the ultimate aim of changing policy.
  Before this, Natasha was a Research Associate at the Primary Care Unit, Department of Public Health and Primary Care, at the University of Cambridge for eight years, where the majority of her work focussed on improving patient experience, with a particular focus on primary care.
  Natasha’s role at MAP consists of researching and developing content for MAP Online and supporting MAP Online members and clients. Natasha brings key research skills, attention to detail, as well as an understanding of the UK health system.

• 

  Oliver Hulisz

  Web Design and Development

  

  Oliver Hulisz

  Web Design and Development

  Oliver Hulisz is head of web design and development at MAP. He has developed more than 50 websites for a range of companies and specialises in WordPress.

  Oliver provides day to day maintenance and updates for the continuously improving and evolving MAP websites as well as ensuring that our technical approach to delivering maximum value to our online clients is always fresh and making the most of the latest available developments. His company 72dpi netzbüro is based in Essen, Germany.

Market Access

• 

  Nick Bruce

  Chief Consulting Officer

  

  Nick Bruce

  Chief Consulting Officer

  Nick worked as an NHS economist and commissioner at Health Authorities in South West London, during which time he held an honorary lectureship at St George’s Hospital Medical School, London. After leaving the NHS, Nick worked for a health economics consultancy before joining Pfizer in 1998 to set up its market access team. In a twenty year pharmaceutical industry career at Pfizer and Amgen, he held UK Leadership Team roles responsible for market access, health policy, government affairs and media communications. Nick was an ABPI representative on the Scottish Medicines Consortium appraisal committee, and a former member of the ABPI Board of Management.

• 

  Lizzy Balman PhD

  Senior Scientific Consultant

  

  Lizzy Balman PhD

  Senior Scientific Consultant

  Lizzy has over 12 years’ experience in market access consulting for the pharmaceutical industry and has in-depth experience of health technology appraisals in the UK and Ireland, where she inputs into the strategy, clinical writing, systematic literature reviews, evidence interpretation and alignment of clinical evidence and health economic modelling. She also has a critical understanding of appraisal processes and timelines, and has managed numerous successful submissions through to final recommendations. Lizzy has worked extensively in rare diseases, has a keen interest in genetic disorders, and has worked across diverse therapeutic areas. Lizzy has a PhD in Immunology.

• 

  David Ringger PhD

  Senior Consultant Market Access

  

  David Ringger PhD

  Senior Consultant Market Access

  David is part of MAP’s Market Access team, assisting pharma, medtech and diagnostic companies in navigating the complexity of bringing new products onto the market.
  Prior to joining MAP Market Access, David worked for 3.5 years at PwC’s Switzerland pharma & life science consulting practice, focusing on market access, R&D, technology and compliance related projects.
  David holds a PhD in organic chemistry from the ETH Zurich, Switzerland and a MChem degree in Chemistry with Medicinal Chemistry from the University of Reading, UK.

• 

  Nermina Ferizović

  Consultant Health Economics and Outcomes Research and Real-world Evidence

  

  Nermina Ferizović

  Consultant Health Economics and Outcomes Research and Real-world Evidence

  Nermina is a health economist specialising in the generation of evidence to highlight both the health benefits and the wider impact of health interventions. Nermina’s role focusses on two key areas of health economics and outcomes research: the assessment of clinical and cost-effectiveness of interventions and real-world evidence generation using worldwide secondary real-world data sources. Nermina designs pharmacoepidemiologic and pharmacoeconomic studies and conducts patient-level data and statistical analyses in R and STATA. In addition, Nermina develops economic models in a wide range of disease areas meaning that a range of modelling techniques are applied including decision trees, Markov models, patient simulation models and epidemiological models. Further, Nermina contributes to the authorship of health technology assessment submissions for worldwide regulatory bodies.
  Nermina holds an MSc in Health Economics and Health Policy from The University of Birmingham and is a member of the Royal Economic Society.
  

• 

  Muksitur Rahman

  Associate Consultant Health Economics and Outcomes Research

  

  Muksitur Rahman

  Associate Consultant Health Economics and Outcomes Research

  Muksit is a member of the HEOR team, having previously held a dual role that straddled both the Health Economics and MAP Online teams. This dual-role facilitated exposure across a broad range of topics including health technology assessment (HTA) submissions, stakeholder mapping, systematic literature reviews and management and analysis of MAP’s in-house database of HTA appraisals. He is also a qualified facilitator for the National Institute for Health and Care Excellence’s (NICE) MedTech Early Technical Assessment (META) Tool. Muksit graduated with a Master's in Economic Evaluation in Healthcare from City University, having previously worked as a pharmacist. He has a special interest in pricing and his dissertation with NHS Improvement compared different costing methods in NHS Trusts.
  

• 

  Jessica Summers

  Clinical Consultant

  

  Jessica Summers

  Clinical Consultant

  Jessica joined MAP in October 2018 as an Associate Consultant. Prior to this she had assisted in the production of numerous systematic literature reviews (SLRs) on a broad range of disease areas, including SLRs required for health technology appraisals (HTAs) for the National Institute for Health and Care Excellence (NICE). Before working in the field of medical communications, she worked for Public Health England in the Microbiology Laboratory and achieved a degree in Natural Sciences from the Open University.

• 

  Aryan Asaadi

  Associate Consultant Health Economics and Outcomes Research

  

  Aryan Asaadi

  Associate Consultant Health Economics and Outcomes Research

  Aryan graduated with a BSc (Hons) in Business Management with a majoring in management consultancy at the Lancaster University Management School. Prior to his career in biopharmaceuticals, Aryan spent two years working in logistics consultancy in Doha, Qatar specialising in healthcare and medical devices. Aryan has also worked in business development roles across tech and maritime sectors in the UK and in the Netherlands. Prior to joining MAP, Aryan worked at a contract research organisation as a pricing and proposals manager working closely with biopharmaceutical clients. He is currently studying an MSc in Health Economics and Policy at the University of Birmingham which made a career in market access and HEOR a natural career move.

• 

  Penny Reeves

  Senior Clinical Consultant

  

  Penny Reeves

  Senior Clinical Consultant

  Penny has over 25 years’ experience in scientific and clinical communications consultancy within the pharmaceutical industry, leading medical writing teams in producing a range of clinical and value communications dossiers, objection handlers, symposium presentations and website content. As a consultant she has worked for Market Access and Medical Affairs functions across a range of disease areas, including rare diseases, neurology and oncology. Penny brings to MAP a wealth of experience in client engagement and programme management, together with an unwavering commitment to editorial excellence and the creation of high-quality, relevant, focused deliverables

• 

  Brian Gavin

  Managing Director, Ireland

  

  Brian Gavin

  Managing Director, Ireland

  Brian Gavin has over twenty-five years’ experience in the healthcare sector across a range of senior management positions both in Ireland and internationally. Most of his industry experience was with GlaxoSmithKline where he held a number of senior management positions including Global Commercial Strategy Manager for Seretide, Commercial Director for GSK Ireland and subsequently Corporate Affairs Director with the company.

  Since 2009, Brian has provided consultancy services to a broad range of pharmaceutical companies including Almirall, Janssen, Biogen IDEC, Reckitt Benckiser, Mundipharma, Takeda, Bausch & Lomb, Bayer and InterMune.

  He has extensive experience in the submission of HTA’s to the National Centre for Pharmacoeconomics and has completed desk and field based research across a broad range of therapy areas. Developed over a number of years Brian has a comprehensive network of contacts across a broad spectrum of stakeholders in the Irish healthcare environment.

• 

  Declan Kinahan

  Market Access Manager

  

  Declan Kinahan

  Market Access Manager

  Declan is a Health Economist with broad experience in both the consultancy and industry environment. He graduated from National University of Ireland Galway (NUIG) with a B Comm in Economics, and gained an MSc in Health Economics from University College Cork (UCC). Declan has worked on wide-raging projects including: the development of HTA submissions and strategies in close collaboration with internal cross-functional teams and external stakeholders (NCPE, NICE, SMC); management of HTA processes and direct communication with associated stakeholders; development of business relationships with customers to promote regional awareness of company’s value proposition. Key attributes and skills Declan brings to the MAP team include HTA experience, project management, client engagement, pricing and reimbursement, and value demonstration.

• 

  Peter Rouse

  Head of Health Economics and Outcomes Research

  

  Peter Rouse

  Head of Health Economics and Outcomes Research

  Peter Rouse is an experienced health economist who joined MAP Biopharma in November 2019 as a Senior Consultant within the HEOR team. Peter has a background in health economic consulting, specialising in health economic modelling for early pricing of assets and HTA submissions, whilst also covering other areas of evidence generation and synthesis, including systematic literature reviews, (network) meta-analysis, preparation of global value dossier, HTA landscape analysis, local reimbursement dossier preparation, and outcomes research using patient-level data. Peter has experience leading successful HTA submissions across Europe, including NICE, SMC and AWMSG, with focus on orphan products and gene therapies for rare disease areas and oncology. Prior to consultancy, Peter worked at the National Clinical Guideline Centre (NCGC) hosted by the Royal College of Physicians, specialising in discrete event simulation modelling for service delivery guidelines, whilst also working on disease specific projects such as type 2 diabetes, palliative care and asthma diagnosis and management. Peter holds a BA in Economics and International Relations from the University of Keele and an MSc in Health Economics and Decision Modelling from the University of Sheffield.

Policy & Public Affairs

• 

  Tessa Hughes

  Associate Director - Head of Policy and Public Affairs

  

  Tessa Hughes

  Associate Director - Head of Policy and Public Affairs

  Tessa has over ten years’ experience in policy and public affairs. She has worked for charities and spent seven years within two award-winning healthcare communications consultancies working across a range of areas, including corporate communications, cancer, cardiovascular disease and diabetes. She has a detailed understanding of the UK health policy environment, including access to medicines issues, levers and incentives and new care models. She has managed a range of successful campaigns, including securing better access to medicines and support for improved cancer awareness.

• 

  Sarah Walker

  Senior Consultant Policy and Public Affairs

  

  Sarah Walker

  Senior Consultant Policy and Public Affairs

  Sarah has over twenty-five years’ experience working in policy and public affairs roles. She worked for a Member of Parliament and for a political publication, before joining a leading public affairs consultancy with a specialist unit dedicated to the health sector. She has worked on both corporate and disease specific public affairs programmes for clients including Merck Sharp & Dohme, Sandoz and the London and Thames Valley Pharmaceutical Group which included some of the UK’s largest pharmaceutical companies. Outside healthcare she has experience of developing strategic public affairs programmes for leading companies including Marks & Spencer and Tate & Lyle. Since joining MAP BioPharma her work has included a significant number of projects in the rare disease arena and she has a detailed knowledge of the key stakeholders in this sector. Sarah has a strong network of contacts and a detailed understanding of the workings of Parliament and the development of policy.

Legal

• 

  Angelika Gornikowska

  Legal Counsel

  

  Angelika Gornikowska

  Legal Counsel

  Angelika graduated from the University of Wroclaw with a Masters’ Degree in Law. Since her studies, Angelika has gained experience in international corporate and commercial law, and subsequently completed a Graduate Diploma in Law course in Cambridge. Angelika has joined MAP to provide support in contract law, as well as help MAP clients and members gain legal input into challenging situations, particularly in the context of regulatory and strategic issues. She also leads the development of MAP Online Legal section with Market Access-related insights in the areas such as intellectual property, data protection, Brexit, ABPI Code of Practice and EU competition law. Angelika also regularly participates in conferences and meeting groups where she helps realise MAP’s vision to accelerate patient access to medicines, medical devices and diagnostics.

• 

  Paul Ranson

  Legal Consultant

  

  Paul Ranson

  Legal Consultant

  Paul Ranson is a lawyer with some 30 years pharmaceutical industry experience. He was formerly an in-house lawyer for Smith Kline, Merck Sharp & Dohme and Eli Lilly before going into private practice where he was a partner of two large international law firms Fasken Martineau and Pinsent Masons. His particular field of expertise is in the EU regulatory and commercial laws affecting pharmaceutical and device companies. This includes some 50 major licensing and product acquisition/divestment transactions. He has been recommended in the main legal directories for life sciences lawyers (Chambers, Legal 500 and others) for some 15 years.

  Beyond legal practice, Paul is a non-executive director of two pharmaceutical companies. He lectures widely and has written or co-written some 10 books or reports on legal issues including collaborations, product liability, outsourcing, pricing and reimbursement and manufacturing and clinical research. He is also the main author of the legal section of the Manchester University MSc on Pharmaceutical Licensing. He is the legal advisor to the Ethical Medicines Industry Group, the trade association for mid-sized pharma companies. He spent 5 years on an IEC.

Operations

• 

  Dawn Hill

  Chief Operating Officer

  

  Dawn Hill

  Chief Operating Officer

  MAP was founded by Dawn who has worked in national and local government departments ranging from Business, Agriculture, Education and Finance for over twenty years.

  This experience was primarily focused on business and administration processes and, importantly for MAP BioPharma, the simplification and efficiency of these processes.

  Dawn therefore founded MAP BioPharma Limited and combines business and administration expertise with contacts in the Health Service, Biotech and Pharmaceutical sectors to deliver valuable resources to support Market Access for medicines in the UK and Ireland.

• 

  Ian Keith

  Operations Director

  

  Ian Keith

  Operations Director

• 

  Laura Carter

  Personal Assistant to CEO and COO

  

  Laura Carter

  Personal Assistant to CEO and COO

  Laura brings to MAP 16 years administration experience and has been in the Pharmaceutical industry for 4 years. Prior to that she was in the Ministry of Defence for 10 years in a variety of roles including information technology. She holds a National Vocational Qualification in Business Administration and an Executive PA Diploma.
  

• 

  Lynne Stoten

  Financial Controller

  

  Lynne Stoten

  Financial Controller

  Lynne is a member of ACCA and holds a BA Hons Degree in Business Economics from Anglian Ruskin University. Lynne has 20 years’ experience working in the finance departments of technology companies which began their lives as start-up businesses, established to develop new technology born from Cambridge University. Lynne has established financial systems and processes which have ensured continuity of the finance function through their transitional program towards to a successful exit strategy and beyond. Lynne joined MAP in June 2017, assisting Dawn Hill, MAP’s Chief Financial Officer, to grow the strong and efficient finance functions within MAP.

• 

  Amanda Wright

  Finance Assistant

  

  Amanda Wright

  Finance Assistant

  Amanda is qualified up to level 3 of the AAT qualification, also holding NVQs in Business Administration levels 2 and 3, and Information Technology level 2. She has over 20 years' experience working within an accounting function, holding various positions. Ten years of this were spent in the bursary of a Cambridge college, and she also has experience working within a financial and insurance services company. Most recently Amanda worked for a Japanese pharmaceutical company within their finance department.

• 

  Adam Charlton

  Associate Director of Technology

  

  Adam Charlton

  Associate Director of Technology

  Adam joined MAP in January 2019 as IT Manager, focusing on Systems Development. Adam contributes over 15 years experience in cross platform software development, system architecture and implementation to the MAP team. Previously, Adam was a member of the Apple Consultants Network, and is an Apple Certified Technical Coordinator.

• 

  Deborah Smith

  Project Manager

  

  Deborah Smith

  Project Manager

  Deborah is a highly effective project and programme manager. She joined MAP with a wealth of experience in managing client accounts and implementing project management excellence throughout organisations. She spent her early career as a research scientist with a focus on genetics, comparative genomics and retrovirology at the NIBSC. She brings consultancy experience from both pharma, and non-pharma, industries having handled a variety of single- and multi-component projects for major global organisations. She has a focus on innovative solutions and making them happen.

• 

  Dovile Varanauskaite

  HR Coordinator

  

  Dovile Varanauskaite

  HR Coordinator

  Dovile joined MAP's HR team in December 2019 to lead on recruitment and other activities. Dovile studied a degree in Business Economics, but quickly started working in HR sector and didn't want to leave. She went on to start a degree in HR, to build her expertise for a career as an HR professional. In her spare time she likes to spend time with her dog, family and friends.

Philanthropy

• 
  

  We support Help for Hope which promotes equal opportunities for all children.

  It was founded by a group of like minded life science professionals, one of whom recently helped us on a personal level. We were touched by their ethical approach whereby all admin costs for the charity are paid for by their own businesses.

  This means that 100% of our donations directly support specific projects to help underpriviledged children, providing them with opportunities to become agents of a better future. Link: help-for-hope.org